The latest GLP-1 drug approved for weight loss, tirzepatide, sold as Zepbound, appears to beat out semaglutide with nearly 19 percent of body weight lost, over 40 pounds (18 kg), with more like five and a half inches (14 cm) off the waist
And the symptom typically resolves within the first four to six weeks of treatment
Psychiatry 29 , 10051019 (2024)
For patients preparing for or recovering from surgery, GLP-1s can help preserve results and support long-term body confidence
4 Use your hands and rub in a circular motion for a couple minutes and repeat this process for other areas while lying on your stomach
These figures are provided for informational and research reference purposes only and do not constitute dosing advice for humans